Literature DB >> 2276142

Synthesis and reactions of leucrose and its exocyclic glycal.

J Thiem1, M Kleeberg.   

Abstract

5-O-alpha-D-Glucopyranosyl-beta-D-fructopyranose (leucrose, 1) was transformed into 3,4-di-O-acetyl-1-O-methanesulfonyl-5-O-(2,3,4-tri-O-acetyl-6-O-methanes ulfonyl-alpha-D-glucopyranosyl)-beta-D-fructopyranosyl bromide (3) and 1,3,4-tri-O-benzoyl-5-O-(2,3,4,6-tetra-O-benzoyl-alpha-D-glucopyranosyl) -beta-D-fructopyranosyl bromide (8), which were converted into derivatives (8 and 9) of 2,6-anhydro-1-deoxy-5-O-alpha-D-glucopyranosyl-D-arabino-hex-1-enitol . Hydrogenation of 8 and 9 gave the corresponding anhydroalditol derivatives. N-Iodosuccinimide-mediated glycosylation of 9 with 1,2,3,4-tetra-O-acetyl-beta-D-glucopyranose gave 1,2,3,4-tetra-O-acetyl-6-O-[3,4-di-O-benzyl-1-deoxy-1-iodo-5-O-(2,3,4,6- tetra-O-benzoyl-alpha-D-glucopyranosyl)-beta-D-fructopyranosyl]- beta-D-glucopyranose (12). Some amino, acetylated, and isopropylidene derivatives of leucrose have been prepared and characterised.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276142     DOI: 10.1016/0008-6215(90)80151-r

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  1 in total

1.  NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium.

Authors:  Jose Manuel Sánchez-Maldonado; Manuel Martínez-Bueno; Helena Canhão; Rob Ter Horst; Sonia Muñoz-Peña; Ana Moñiz-Díez; Ana Rodríguez-Ramos; Alejandro Escudero; Signe B Sorensen; Merete L Hetland; Miguel A Ferrer; Bente Glintborg; Ileana Filipescu; Eva Pérez-Pampin; Pablo Conesa-Zamora; Antonio García; Alfons den Broeder; Salvatore De Vita; Svend Erik Hove Jacobsen; Eduardo Collantes; Luca Quartuccio; Mihai G Netea; Yang Li; João E Fonseca; Manuel Jurado; Miguel Ángel López-Nevot; Marieke J H Coenen; Vibeke Andersen; Rafael Cáliz; Juan Sainz
Journal:  Sci Rep       Date:  2020-03-09       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.